AssemblyAI's blog post explores the decision for product teams building clinical applications to either buy an off-the-shelf AI medical scribe like Nuance DAX Copilot or Abridge, or to build their own solution. Buying offers immediate functionality and EHR integration but sacrifices control over note format, specialty coverage, and long-term economics. Building provides ownership of the entire stack, enabling customization and better margins, but requires significant development effort across speech-to-text, speaker diarization, and note generation. AI
IMPACT Guides product teams on strategic decisions regarding AI scribe integration, impacting development focus and cost structures.
RANK_REASON Blog post discussing build vs. buy decision for a specific type of AI tool.
AI-generated summary · Google Gemini · from 1 sources. How we write summaries →
